Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Published July 29, 2026 · Recall initiated: June 26, 2026
Summary
FDA records drug Class II recall D-0742-2026, published July 29, 2026 and initiated June 26, 2026. Recalling firm: Bionpharma Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot# 704C003, Exp. 12/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if DIVALPROEX SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- Bionpharma Inc.
- Distributor
- US Nationwide.
- Lot
- Lot# 704C003, Exp. 12/31/2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, ILJuly 29, 2026
- FDATrokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: CatalentJuly 29, 2026
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDADivalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, ManufacturedAugust 31, 2022
- FDADivalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun PharmaceuticalAugust 3, 2022
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy'sFebruary 27, 2019
Questions about this recall
Was Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. recalled?
Yes. FDA published recall D-0742-2026 on July 29, 2026. Reported hazard: Presence of Foreign Tablets/Capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIVALPROEX SODIUM.